Low prevalence of influenza A strains with resistance markers in Brazil during 2017-2019 seasons

• Үндсэн зохиолчид: Thiago das Chagas Sousa (Зохиогч), Jessica Santa Cruz Carvalho Martins (Зохиогч), Milene Dias Miranda (Зохиогч), Cristiana Couto Garcia (Зохиогч), Paola Cristina Resende (Зохиогч), Cliomar A. Santos (Зохиогч), Maria do Carmo Debur (Зохиогч), Rodrigo Ribeiro Rodrigues (Зохиогч), Andrea Cony Cavalcanti (Зохиогч), Tatiana Schäffer Gregianini (Зохиогч), Felipe Campos de Melo Iani (Зохиогч), Felicidade Mota Pereira (Зохиогч), Sandra Bianchini Fernandes (Зохиогч), Jessylene de Almeida Ferreira (Зохиогч), Katia Correa de Oliveira Santos (Зохиогч), Fernando Motta (Зохиогч), David Brown (Зохиогч), Walquiria Aparecida Ferreira de Almeida (Зохиогч), Marilda Mendonça Siqueira (Зохиогч), Aline da Rocha Matos (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Frontiers Media S.A., 2022-09-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

The influenza A virus (IAV) is of a major public health concern as it causes annual epidemics and has the potential to cause pandemics. At present, the neuraminidase inhibitors (NAIs) are the most widely used anti-influenza drugs, but, more recently, the drug baloxavir marboxil (BXM), a polymerase i...